跳至主要内容
临床试验/IRCT20201117049420N1
IRCT20201117049420N1已完成3 期

Evaluation of the effect of Colchicine on incidence of Major Adverse Cardiac Events (MACE) in the patients with Acute Coronary Syndrome (ACS) during the first 6 months of Colchicine use

Shiraz University of Medical Sciences0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
All

入选标准

  • Patients who have completed the informed consent form
  • Patients aged 40-70 years with history of chest pain who have undergone Coronary Angiography with the aim of medical treatment or who have undergone Total or Near Total Revascularization
  • Whose information and follow ups are completed

排除标准

  • 1. Patients with history of hypersensitivity to Colchicine
  • 2. Patients with history of Moderate Renal Dysfunction (GFR<50)
  • 3. Patients with history of Hepatic Dysfunction (ALT> 1.5 * ULN)
  • 4. Patients with history of Thrombocytopenia and or Leukopenia
  • 5. Pregnant patient, Lactating women, and women at risk of Pregnancy
  • 6. Patients who are already taking Colchicine
  • 7. Patients who have undergone CABG (Coronary Artery Bypass Grafting)
  • 8. Patients with LVEF less than 30%

研究者

相似试验